Shandong Suncadia Medicine Co., Ltd. clinical trials

A subsidiary of Jiangsu HengRui Medicine Co., Ltd.

The registry lists 87 studies whose lead sponsor is Shandong Suncadia Medicine Co., Ltd.. 40 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 20, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 87. List all 87 → · All Jiangsu HengRui Medicine Co., Ltd. studies →

• A Trial of HRS-1780 in Participants With Uncontrolled Hypertension or Resistant Hypertension.RecruitingNCT07708441Phase 2/3

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Drug-Drug Interaction Study of Rifampicin and Oral HRS-8080Not yet recruitingNCT07876596Phase 1

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast CancerRecruitingNCT07024173Phase 3

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• Phase III Study of HRS-7535 for Hypertension With Overweight or ObesityRecruitingNCT07528027Phase 3

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• Safety and Pharmacokinetics of HRS-1597 Tablets in Healthy and Obese Participants: A Phase 1 StudyNot yet recruitingNCT07808918Phase 1

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• Clinical Study of HRS-2129 for Acute Gouty ArthritisRecruitingNCT07706777Phase 2

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Clinical Study of HRS-7156 in Healthy ParticipantsRecruitingNCT07601087Phase 1

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• Study of Oral HRS-5346 in Adult Patients With Elevated Lipoprotein(a) and High Risk of Cardiovascular EventsNot yet recruitingNCT07767513Phase 2

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• Phase I Clinical Study Evaluating the Relative Bioavailability of Different Formulations of HRS-5346 in Healthy ParticipantsNot yet recruitingNCT07752069Phase 1

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of Patients With Chronic Kidney DiseaseRecruitingNCT07419828Phase 3

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• Human Mass Balance Study of [¹⁴C]HRS-1893Not yet recruitingNCT07656779Phase 1

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With Pancreatic CancerRecruitingNCT07589569Phase 2

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• Renal Efficacy and Safety of the Novel Oral Small-Molecule GLP-1RA HRS-7535 Evaluated in Participants With Chronic Kidney DiseaseNot yet recruitingNCT07625774Phase 3

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel DiseaseRecruitingNCT07229950Phase 2

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Study to Evluate Efficacy and Safety of HRS-8080 Combined With Dalpiciclib in Patients With Advanced or Metastatic Breast Cancer Resistant to Adjuvant Endocrine Therapy.RecruitingNCT07354022Phase 3

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Phase I/II of HRS-6719 in Patients With Advanced/Metastatic Solid TumorsRecruitingNCT06922357Phase 1/2

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast CancerRecruitingNCT07349069Phase 3

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard TreatmentNot yet recruitingNCT07601048Phase 3

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection FractionRecruitingNCT07269717Phase 2

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Mass Balance Study of [14C]HRS-1780 in Healthy Adult Male SubjectsNot yet recruitingNCT07557407Phase 1

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic PainRecruitingNCT07377721Phase 1

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast CancerRecruitingNCT07389733Phase 1/2

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HRS-3802 Monotherapy in Patients With Malignant Solid TumorsRecruitingNCT06770569Phase 1

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Clinical Trial of HRS-7058 Combined Anti-tumor Drugs in Subjects With Solid TumorsRecruitingNCT07032077Phase 2

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer PatientsRecruitingNCT06679036Phase 1/2

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Phase II Clinical Study of HRS-7058 in Combination With Antitumor Drugs in Patients With Advanced Malignant TumourRecruitingNCT06915142Phase 2

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant TumourRecruitingNCT06383871Phase 1

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• Clinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable or Metastatic Breast CancerRecruitingNCT06167694Phase 1/2

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• Study on the Efficacy and Safety of HRS-7535 in Patients With Mild Decrease in Ejection Fraction/Preserved Ejection Fraction Heart Failure and ObesityRecruitingNCT06820099Phase 2

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• Multicenter Phase I Study of HRS-6208 in Patients With Solid TumorsRecruitingNCT06727812Phase 1

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With DyslipidemiaRecruitingNCT07229937Phase 2

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Phase Ⅱ/Ⅲ Study of HRS-2129 for Postsurgical Pain Management in Abdominal SurgeryRecruitingNCT07185594Phase 2/3

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic CardiomyopathyRecruitingNCT07021963Phase 2

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Trial of HRS-1358 Tablets in Metastatic or Local Advanced Breast CancerRecruitingNCT05628870Phase 1

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast CancerRecruitingNCT06222879Phase 1/2

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• Drug-drug Interaction Study of HRS-1780 Tablets in Healthy SubjectsNot yet recruitingNCT06344936Phase 1

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Phase I Clinical Trial Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Oral Doses of HRS-7085 Tablets in Healthy Subjects, With Assessment of Food EffectsNot yet recruitingNCT06175949Phase 1

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal FunctionNot yet recruitingNCT06039254Phase 1

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• Phase I Clinical Study of HRS-2189 in the Treatment of Patients With Advanced Malignant TumorsRecruitingNCT05851092Phase 1

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Trial of HRS-8080 Tablets in Metastatic or Local Advanced Breast Cancer of AdultsEnrolling by invitationNCT05189717Phase 1

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Phase II Clinical Study on the Efficacy and Safety of HRS-1780 in Participants With Primary AldosteronismActive, not recruitingNCT07470983Phase 2

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1301 in Healthy SubjectsCompletedNCT06857253Phase 1

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney FunctionCompletedNCT07322016Phase 1

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Study to Assess the Effect of HRS-1301 on the Pharmacokinetics of Midazolam and Atorvastatin in Healthy ParticipantsCompletedNCT07608705Phase 1

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee OsteoarthritisCompletedNCT07351968Phase 1

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Clinical Study Comparing the Bioavailability of HRS-2189 TabletsCompletedNCT07639905Phase 1

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy ParticipantsCompletedNCT07479641Phase 1

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese SubjectsCompletedNCT06621316Phase 1/2

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic CardiomyopathyCompletedNCT06816251Phase 2

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.

• A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic CardiomyopathyActive, not recruitingNCT07021976Phase 3

  Sponsor listed in the registry: Shandong Suncadia Medicine Co., Ltd.